Thrombolytic therapy during resuscitation for pulmonary embolism-related out-ofhospital cardiac arrest: perhaps not the ideal solution for everyone Patrick M. Honore * , Cristina David, Aude Mugisha, Rachid Attou, Sebastien Redant, Andrea Gallerani and David De Bels Javaudin et al. [1] recommended that for cases of out-ofhospital cardiac arrest (OHCA) for which a cause is not obvious, pulmonary embolism (PE) should be suspected if the initial rhythm is nonshockable and there is a history of thromboembolism (TE). In accordance with the guidelines of the American Heart Association, these patients could be treated with systemic thrombolysis (ST) during resuscitation (low level of evidence) [1] . We would like to add some comments. First, recent studies have shown that ultrasound-facilitated catheter fibrinolysis relieves right ventricular pressure overload with a lower risk of major bleeding and intracranial hemorrhage than historical rates with ST [2] . However, further research is required to determine the optimal application of this technique in the setting of acute PE [2] . Second, the insertion of an emergency veno-arterial extracorporeal membrane oxygenation (VA-ECMO) catheter should be considered before starting ST. VA-ECMO can be a lifesaving therapeutic consideration, either as an adjunct to definitive management strategies (surgical/catheter embolectomy, thrombolysis) or on its own [3] . According to a recent systematic review, VA-ECMO for selected patients with massive PE is associated with good outcome [3] .
Third, after failure of thrombolysis, surgical embolectomy or catheter embolectomy should be considered in selected centers [3] . Fourth, published cases of thrombolysis for massive PE during pregnancy and the postpartum period suggest acceptable maternal and fetal survival even with CA [4] . In the postpartum period, given the high risk of major bleeding with thrombolysis, other therapeutic options (catheter or surgical thrombectomy, VA-ECMO) should be considered if available [4] . Lastly, chronic thromboembolic pulmonary hypertension (CTEPH) is a pulmonary vascular disease caused by chronic obstruction of major pulmonary arteries and often occurs after an initial PE or TE [5] . The authors note the importance of a past history of PE or TE as a risk factor and should therefore consider CTEPH as well. CTEPH can be cured by pulmonary endarterectomy (PEA), a challenging procedure for which patient selection and perioperative management are complex, requiring significant experience [5] . We had a 45-year-old patient with CTEPH who, after failed thrombolysis, was transferred to another center for PEA and achieved a full recovery [5] . Thrombolysis may not be the cure for everyone. A clear step by step approach should be considered in case of failed thrombolysis. 
